全文获取类型
收费全文 | 252360篇 |
免费 | 17597篇 |
国内免费 | 5264篇 |
专业分类
耳鼻咽喉 | 3301篇 |
儿科学 | 6821篇 |
妇产科学 | 5271篇 |
基础医学 | 27696篇 |
口腔科学 | 6471篇 |
临床医学 | 22558篇 |
内科学 | 46786篇 |
皮肤病学 | 6591篇 |
神经病学 | 15969篇 |
特种医学 | 7556篇 |
外国民族医学 | 31篇 |
外科学 | 28817篇 |
综合类 | 22371篇 |
现状与发展 | 13篇 |
一般理论 | 38篇 |
预防医学 | 28704篇 |
眼科学 | 4408篇 |
药学 | 20891篇 |
119篇 | |
中国医学 | 8940篇 |
肿瘤学 | 11869篇 |
出版年
2023年 | 2318篇 |
2022年 | 4257篇 |
2021年 | 7126篇 |
2020年 | 5128篇 |
2019年 | 5249篇 |
2018年 | 7051篇 |
2017年 | 5845篇 |
2016年 | 5352篇 |
2015年 | 7228篇 |
2014年 | 9173篇 |
2013年 | 12719篇 |
2012年 | 17457篇 |
2011年 | 18121篇 |
2010年 | 12967篇 |
2009年 | 11535篇 |
2008年 | 14766篇 |
2007年 | 14934篇 |
2006年 | 14026篇 |
2005年 | 12832篇 |
2004年 | 11047篇 |
2003年 | 9908篇 |
2002年 | 9156篇 |
2001年 | 7041篇 |
2000年 | 6622篇 |
1999年 | 5109篇 |
1998年 | 1667篇 |
1997年 | 1314篇 |
1996年 | 1260篇 |
1995年 | 1057篇 |
1994年 | 871篇 |
1993年 | 803篇 |
1992年 | 2413篇 |
1991年 | 2278篇 |
1990年 | 2121篇 |
1989年 | 1902篇 |
1988年 | 1744篇 |
1987年 | 1688篇 |
1986年 | 1576篇 |
1985年 | 1505篇 |
1984年 | 1120篇 |
1983年 | 969篇 |
1979年 | 1025篇 |
1978年 | 688篇 |
1975年 | 696篇 |
1974年 | 890篇 |
1973年 | 857篇 |
1972年 | 758篇 |
1971年 | 713篇 |
1970年 | 757篇 |
1969年 | 717篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
目的评价NA:YAG激光虹膜切除术治疗原发性闭角型青光眼和葡萄膜炎继发青光眼的临床疗效。方法回顾分析192例219眼原发性闭角型青光眼和9例葡萄膜炎继发青光眼,接受NA:YAG激光虹膜切除术后的临床效果,随诊16—46月。结果激光切孔一次成功205眼(占89e),激光能量在11—17.1mJ,67%病例在22—84Mj,击射次数2-33次。葡萄膜炎继发青光眼9眼均二次激光后虹膜孔通畅。95.61%术后眼压正常,视野无变化,术后早期一过性眼压升高占34%,术中出血占36%,房角色素增加占47%,1例术后28月接受小量切除术,8例术后需配合使用降眼压药物控制眼压。结论NA:YAG激光虹膜切除术是一种治疗闭角型青光眼的安全有效的方法。术前掌握适应症,把握手术时机,充分的术前准备是手术成功的关键。 相似文献
92.
肾移植术后并发尿路上皮肿瘤的临床分析 总被引:8,自引:0,他引:8
目的 分析肾移植患者并发尿路上皮肿瘤的特点,探讨其诊治方法。方法 自1998~2003年肾移植患者1293例,术后发生尿路上皮恶性肿瘤21例(1.6%)。男4例,女17例。17例原发病为慢性问质性肾炎。发生尿路上皮肿瘤距肾移植6~62个月,平均26个月。其中膀胱癌6例,单侧肾盂或输尿管癌6例,单侧肾盂或输尿管、膀胱癌8例,双侧肾盂输尿管癌1例。10例上尿路肿瘤发生部位与移植肾同侧,4例发生于移植肾对侧。临床症状以无痛性肉服血尿和反复泌尿系感染为主。19例行手术治疗,术后所有患者免疫抑制剂用量减少1/3并辅以局部灌注化疗。结果 2例行姑息性治疗的晚期肿瘤患者分别于发现肿瘤5、8个月死亡。余19例现已随访2~5年。13例肿瘤复发,复发部位为膀胱或对侧原。肾、输尿管。所有患者在免疫抑制剂减量期间均未出现急性排斥。2例因切除移植肾恢复透析,17例肾功能正常。结论 慢性间质性。肾炎导致。肾功能衰竭的。肾移植患者和女性肾移植患者易发生移植后尿路上皮肿瘤;移植肾同侧上尿路较对侧好发肿瘤;对移植肾对侧为首发的上尿路发生肿瘤者可预防性行双侧上尿路根治性切除。 相似文献
93.
Benedita Sampaio-Maia Mónica Moreira-Rodrigues Paula Serr?o Manuel Pestana 《Nephrology, dialysis, transplantation》2006,21(2):314-323
BACKGROUND: A primary tubular sodium handling abnormality has been implicated in the edema formation of nephrotic syndrome. Dopamine synthesized by renal proximal tubules behaves as an endogenous natriuretic hormone by activating D(1)-like receptors as a paracrine/autocrine substance. METHODS: We examined the time courses of the urinary excretion of sodium, protein and dopamine in puromycin aminonucleoside (PAN)-treated and control rats. The rats were sacrificed during greatest sodium retention (day 7) as well as during negative sodium balance (day 14) for the evaluation of renal aromatic l-amino acid decarboxylase (AADC) activity, the enzyme responsible for the synthesis of renal dopamine. Also, the influence of volume expansion (VE) and the effects of the D(1)-like agonist fenoldopam (10 microg/kg bw/min) on natriuresis and on proximal tubular Na(+),K(+)-ATPase activity were examined on day 7. RESULTS: The daily urinary excretion of dopamine was decreased in PAN-treated rats, from day 5 and beyond. This was accompanied by a marked decrease in the renal AADC activity, on days 7 and 14. During VE, the fenoldopam-induced decrease in proximal tubular Na(+),K(+)-ATPase activity was more pronounced in PAN-treated rats than in controls. However, the urinary sodium excretion during fenoldopam infusion was markedly increased in control rats but was not altered in PAN-treated animals. CONCLUSION: PAN nephrosis is associated with a blunted renal dopaminergic system activity which may contribute to enhance the proximal tubular Na(+),K(+)-ATPase activity. However, the lack of renal dopamine appears not to be related with the overall renal sodium retention in a state of proteinuria. 相似文献
94.
95.
曲美他嗪治疗冠心病心力衰竭的临床观察 总被引:16,自引:1,他引:15
目的观察曲美他嗪治疗冠心病心力衰竭的临床疗效和安全性。方法选择冠心病心力衰竭患者86例,左心室射血分数(LVEF)均小于40%,NYHA心功能分级在Ⅲ~Ⅳ级。随机分成2组,对照组给予血管紧张素转换酶抑制剂(ACEI)或血管紧张素Ⅱ受体拮抗剂(ARB)、β-受体阻滞剂、利尿剂、醛固酮拮抗剂和洋地黄等基础药物治疗;治疗组在上述基础治疗上加用曲美他嗪20mg,3次/d治疗。观察时间为6个月。结果治疗组与对照组相比,3个月和6个月时LVEF、心功能分级及6min步行试验结果改善明显(P<0.05),且6个月较3个月时改善更明显,再住院次数亦明显减少,不良反应较少。结论曲美他嗪治疗冠心病心力衰竭的作用明显,是一种安全有效的新方法,其机制可能与改善缺血心肌的能量代谢有关。 相似文献
96.
Yaprak Engin-Ustün Yusuf Ustün M Mutlu Meydanli Ay?e Kafkasli 《Gynecological endocrinology》2006,22(12):676-679
AIM: To compare the effects of 17beta-estradiol given intranasally (intranasal E2) and raloxifene on serum lipid profile and fibrinogen in hypercholesterolemic postmenopausal women. METHODS: The study population consisted of 46 women after menopause. The placebo group (n = 11) was given calcium, while the intervention groups were given intranasal E2 (Aerodiol; Servier, Chambray-les-Tours, France) (n = 16) or raloxifene (Evista; Lilly SA, Madrid, Spain) (n = 19). Blood lipids and fibrinogen were compared between groups at baseline and after 3 months of treatment. RESULTS: The group receiving intranasal E2 showed a significant decrease in triglyceride levels (p<0.05) and a marked increase in high-density lipoprotein cholesterol levels (p<0.05). No changes in lipid profile were observed in the raloxifene and placebo groups. Raloxifene caused a significant decrease in fibrinogen levels (p<0.05). CONCLUSION: Intranasal E2 exerts significant effects on lipid profile in hypercholesterolemic postmenopausal women. Raloxifene has a greater impact on fibrinogen than intranasal E2 application. 相似文献
97.
K. Sjölund S. Fasth R. Ekman L. Hultén H. Jiborn S. Nordgren & F. Sundler 《Neurogastroenterology and motility》1997,9(3):143-150
Tissue specimens from the large bowel of 18 patients with long-standing slow transit constipation were investigated to determine the distribution and density of several neuropeptides and amines in the enteric nerve system, and also of endocrine cells in comparison to normal individuals. CGRP (calcitonin gene-related peptide), galanin, glucagon, GRP (gastrin-releasing peptide), metenkephalin, motilin, neuropeptide Y (NPY), PACAP, peptide YY (PYY), serotonin, somatostatin, substance P and VIP were studied by immunohistochemistry. Tissue concentrations of VIP, substance P and galanin were also measured by radioimmunoassay. Significantly increased VIP, SP and galanin contents were found in specimens from the ascending colon. Levels of VIP and galanin were also increased in the transverse colon. Immunohistochemistry revealed only marginal changes with an increased density of PACAP nerve fibres in the smooth muscle and of VIP and PACAP nerves in the myenteric plexus of the transverse colon. In the descending colon substance P and NPY immunoreactivity were also increased in the myenteric plexus while the density of VIP nerve fibres was reduced in the mucosa/submucosa. The frequency of PYY-containing cells and the 5-HT-containing cells in the ascending colon was significantly increased in the constipated patients. 相似文献
98.
99.
The degree of metabolic acidosis at birth has been calculated in cord artery and vein samples from 21 term fetuses with cord artery pH less than 7.20. The aim of the study was to compare base deficit values calculated from either Siggaard-Andersen alignment nomogram (BD blood) or the Acid-Base chart (BD extra cellular fluid, BDecf). BDblood was found to be consistently higher in the cord artery as compared with BDecf, 13.2 +/- 3.5 and 9.9 +/- 2.9 mmol/l (Mean +/- SD), respectively. A significant correlation was found between cord artery PCO2 and BDblood whereas BDecf appeared unaffected by PCO2. In cases with cord entanglement BDecf a-v differences were increased to 3.4 +/- 2.3 mmol/l as compared with the small a-v difference noted in acidotic cases without cord entanglement, 1.1 +/- 1.25 mmol/l. It is speculated that with acutely emerging, intermittent asphyxia due to cord compression, a cord artery and vein difference in metabolic acidosis may exist and where the vein captures the basal level and the artery the acute changes. It is concluded that BDecf in both cord artery and vein add valuable information on the mechanisms behind metabolic acidosis. 相似文献
100.